Beyond market averages, investors seeking exceptional growth focus on the art of stock selection. The right picks can significantly contribute to the expansion of your wealth.
The closing price of Cognex Corp (NASDAQ: CGNX) was $44.18 for the day, up 4.69% from the previous closing price of $42.2. In other words, the price has increased by $4.69 from its previous closing price. On the day, 2.44 million shares were traded. CGNX stock price reached its highest trading level at $44.21 during the session, while it also had its lowest trading level at $42.95.
Ratios:
Our analysis of CGNX’s different ratios will help us gain a deeper understanding of the company. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 32.51 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 41.29. For the most recent quarter (mrq), Quick Ratio is recorded 2.45 and its Current Ratio is at 3.21. In the meantime, Its Debt-to-Equity ratio is 0.06 whereas as Long-Term Debt/Eq ratio is at 0.05.
On July 10, 2025, Melius Upgraded its rating to Buy which previously was Hold but kept the price unchanged to $60.
TD Cowen Upgraded its Hold to Buy on April 28, 2025, while the target price for the stock was maintained at $35.
Insider Transactions:
Also, insider trades can serve as a great indicator of what management thinks about the future direction of a stock’s price. A recent insider transaction in this stock occurred on Mar 11 ’25 when Kuechen Joerg sold 7,991 shares for $32.97 per share. The transaction valued at 263,469 led to the insider holds 0 shares of the business.
JOERG KUECHEN bought 7,991 shares of CGNX for $263,469 on Mar 11 ’25. On Feb 24 ’25, another insider, Gerst Carl, who serves as the EVP, Vision & ID Products of the company, sold 6,803 shares for $32.73 each. As a result, the insider received 222,630 and left with 4,566 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, CGNX now has a Market Capitalization of 7417778176 and an Enterprise Value of 7272760320. As of this moment, Cognex’s Price-to-Earnings (P/E) ratio for their current fiscal year is 61.83, and their Forward P/E ratio for the next fiscal year is 38.07. The expected Price-to-Earnings-to-Growth (PEG) calculation for the next 5 years is 1.94. For the stock, the TTM Price-to-Sale (P/S) ratio is 7.98 while its Price-to-Book (P/B) ratio in mrq is 4.93. Its current Enterprise Value per Revenue stands at 7.824 whereas that against EBITDA is 44.201.
Stock Price History:
The Beta on a monthly basis for CGNX is 1.50, which has changed by 0.12302995 over the last 52 weeks, in comparison to a change of 0.16657472 over the same period for the S&P500. Over the past 52 weeks, CGNX has reached a high of $44.17, while it has fallen to a 52-week low of $22.67. The 50-Day Moving Average of the stock is 29.78%, while the 200-Day Moving Average is calculated to be 29.10%.
Shares Statistics:
CGNX traded an average of 1.86M shares per day over the past three months and 2819090 shares per day over the past ten days. A total of 167.90M shares are outstanding, with a floating share count of 167.43M. Insiders hold about 0.28% of the company’s shares, while institutions hold 95.41% stake in the company. Shares short for CGNX as of 1753920000 were 5337958 with a Short Ratio of 2.86, compared to 1751241600 on 5761618. Therefore, it implies a Short% of Shares Outstanding of 5337958 and a Short% of Float of 3.56.
Dividends & Splits
With its trailing 12-month dividend rate of 0.315, CGNX has a forward annual dividend rate of 0.39. Against a Trailing Annual Dividend Yield of 0.007464455The stock’s 5-year Average Dividend Yield is 0.56. The current Payout Ratio is 49.59% for CGNX, which recently paid a dividend on 2025-05-15 with an ex-dividend date of 2025-08-14. Stock splits for the company last occurred on 2017-12-04 when the company split stock in a 2:1 ratio.
Earnings Estimates
The market rating of Cognex Corp (CGNX) is currently shaped by the ongoing analysis conducted by 15.0 analysts closely monitoring its performance.The consensus estimate for the next quarter is $0.22, with high estimates of $0.25 and low estimates of $0.19.
Analysts are recommending an EPS of between $0.98 and $0.86 for the fiscal current year, implying an average EPS of $0.92. EPS for the following year is $1.16, with 17.0 analysts recommending between $1.55 and $1.02.
Revenue Estimates
It is expected that $90B in revenue will be generated in the current quarter, according to 16 analysts. It ranges from a high estimate of $269.88M to a low estimate of $246M. As of the current estimate, Cognex Corp’s year-ago sales were $234.74MFor the next quarter, 16 analysts are estimating revenue of $237.09M. There is a high estimate of $240M for the next quarter, whereas the lowest estimate is $234M.
A total of 19 analysts have provided revenue estimates for CGNX’s current fiscal year. The highest revenue estimate was $986.46M, while the lowest revenue estimate was $943M, resulting in an average revenue estimate of $965.58M. In the same quarter a year ago, actual revenue was $914.51MBased on 19 analysts’ estimates, the company’s revenue will be $1.06B in the next fiscal year. The high estimate is $1.15B and the low estimate is $1.03B.
